Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Slides:



Advertisements
Similar presentations
Dr. Amal S. Ahmed Ass Prof.Clinical Pathology Suez Canal University
Advertisements

Diagnostic tests include: Physical examination Laboratory tests Imaging Endoscopic examination Biopsy Surgery Molecular testing How is cancer diagnosed?
Tumor Biology and Lab diagnosis
TUMOR MARKERS Prof. Dr.Yıldız DİNÇER.
Joint Hospital Surgical Grand Round
Metastatic bone tumor Maher swaileh.
Neoplasia 1: Introduction. terminology oncology: the study of tumors neoplasia: new growth (indicates autonomy with a loss of response to growth controls)
Neoplasia I Introduction Husni Maqboul, M.D. Terminology Tumor : Pathologic disturbance of growth, characterized by excessive and unnecessary proliferation.
Introduction to Pathology. What is pathology Pathology is the scientific study of disease. In its broadest sense, it is the study of how the organs and.
Doç.Dr. Jale Çoban Klinik Biyokimya Uzmanı
Cancer Dr. Raid Jastania. Cancer In the US: 1.3 million new cancer cases in 2002 >500,000 death of cancer Increase cancer death in men due to lung cancer.
Lecture 4. Special chemistry Definition Special Chemistry is a subsection of the Chemistry Laboratory of the Division of Clinical Pathology. This includes.
NEOPLASIA Lecture 5 Dr. Maha Arafah.
Tumor Markers Dr/ Ehsan Mohamed Rizk. A substance that is present in or produced by a tumor or by the host in response to tumor’s presence. An ideal tumor.
Plasma proteins Lecture 3.
Eleni Galani Medical Oncologist
Tumor Markers: Clinical Usefulness
Tumor Markers By: dr. hassan el-banna.
بسم الله الرحمن الرحيم.
Neoplasia I Walter C. Bell, M.D..
Epidemiology of cancer:. Cancer incidence:  In males: Cancers of the lung, prostate, and colon are the leading causes of cancer deaths.  In females.
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
BY DR. KHANSA IQBAL SENIOR REGISTRAR GYNAE UNIT-II.
EKUSILENI CLINICAL LABORATORY
MHD II Laboratory Session Cytology APRIL 24, 2014.
Tumor Markers Lecture two By Dr. Reem Sallam. Objectives  To briefly enumerate the most commonly used methods to test for tumor markers  To describe.
Principles of Surgical Oncology Salah R. Elfaqih.
Principles of Surgical Oncology Salah R. Elfaqih.
Metastatic Cancer – Gross Pathology Lymph node - metastasis from breastLiver – metastasis from lung Vertebral column – metastasis from prostate Mesentery.
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Tumormarkers.
Notes by Dr Sanjay A Pai. Neoplasm An abnormal proliferation of cells, resulting in a mass called a neoplasm.
Cancer Biology Tumour Markers Tumour Markers Prof. Kenneth Bagshawe FRS.
Tumor Markers.
Neoplasia-2.
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
6/2/2016Naglaa Alhusseini1 TUMOR MARKERS Naglaa Fathy Alhusseini Ass.Prof. of Biochemistry and Molecular Biology
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
Introduction to pathology Dr. Amitabha Basu MD. What is Pathology ? It is the study (logos) of the sufferings (pathos).
Principles of Grading & Staging of Malignant Tumors with Local & Systemic Manifestations Slides were taken from Dr. Amany Fathaddin, MD Assistant professor-
Lecture 11 Immunology Tumor immunology Dr: Dalia Galal.
Principles of Surgical Oncology
Introduction to pathology Introduction to pathology Medical College Of Inner Mongolia University For Nationalities Medical College Of Inner Mongolia University.
Tumor Markers.
Introduction to Pathology
NEOPLASIA CASES. CASE 1 A 20 year old female presented with a round mobile breast lump. She has no family history of breast cancer Question : What test.
Neoplasia 7 Dr. Hiba Wazeer Al Zou’bi. Clinical aspects of neoplasia Both malignant and benign tumors may cause problems because of (1) location and impingement.
Malignant Mesothelioma in Effusions and Fine Needle Aspirates No relationship exists that represents a possible conflict of interest with respect to the.
NEOPLASIA -4 Dr Samal Nauhria Viral and Bacterial Oncogenesis HTLV-1 : a retrovirus, endemic in Japan, the Caribbean, and parts of.
LABORATORY EXAMINATION OF CANCER Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology.
Cytology of Body Fluid Pleural peritoneal pericardial
Unit 6: Tumor markers. Introduction… Cancer is the second leading cause of death in North America, accounting for > 2.7 million deaths annually Although.
Lecture 10: Diagnosis of cancer Learning objectives: This lecture provides an understanding of various approaches in the diagnosis of malignancy Learning.
Neoplasia Basics, Grading and Staging Kimiko Suzue MD, Ph.D. Department of Pathology Mt. Sinai Hospital.
Tumor markers Definition Cancer Carcinogenic agents, Endocrine factors Oncogenic viruses, and Ionizing radiation Metastasis Main tumor markers CEA, AFP,
GRADING AND STAGING OF TUMORS Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma’ah Univeristy.
Common pitfall in Oncology Luangyot Thongthieang, MD MEDICAL ONCOLOGY UNIT INTERNAL MEDICINE, KHONKAEN HOSPITAL.
NEOPLASIA DR. AYESHA IMTIAZ PATHOLOGY DR. AYESHA IMTIAZ PATHOLOGY.
SURGICAL ONCOLOGY AND TUMOR MARKERS
Cytopathology Laboratory
Principles of Surgical Oncology
Amany Fathaddin,MD Assistant professor Department of Pathology
Tumor Marker Tests.
Introduction to Pathology DR:Gehan mohamed
ד"ר שרית בר ששת בי"ח בילינסון
Neoplasia (6 of 6) Ali Al Khader, M.D. Faculty of Medicine
Introduction to Pathology By Dr. Gehan Mohamed Dr. Abdelaty Shawky
CLINICAL FEATURES OF NEOPLASIA
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
ROYAL COLLEGE OF PHYSICIANS,
Presentation transcript:

Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers

Histological methods - Frozen Section Used per-operatively To determine nature of mass lesion - whether inflammatory / benign / malignant To evaluate sentinel node status, margins of excised cancer

Cytological Methods - Fine Needle Aspiration Cytology Using regular small bore needle : readily palpable sites – breast, lymph node, thyroid Using special needle: prostate Using ultrasound/CT guidance: deep seated structures also

Cytological Methods - Exfoliative Cytology Pap smears : Carcinoma cervix Ascitic / pleural fluid cytology Cerebrospinal fluid

Immunohistochemistry Categorizing undifferentiated malignancies Categorizing leukemia / lymphomas Determining site of origin of metastasis Detecting molecules of prognostic / therapeutic significance

Immunohistochemical stains Carcinomas: Cytokeratin, EMA, CEA Sarcomas: Vimentin Muscle derived sarcomas: Desmin, Actin Tumors of endothelium: Factor VIII, CD31 Leukocyte malignancies 1.CD 45: LCA (Leukocyte common antigen) - almost all except mature RBCs 2.CD 19, 20: B Cell Lymphoma 3.CD 3, 5, 7, 4, 8: T cell Lymphoma 4.CD 15+, CD30+ : Hodgkin’s Lymphoma Neural crest derived tumors: S100 +ve 1. Neuroendocrine tumors(carcinoid) : S 100 & Chromogranin 2. Neural tumors (neuroblastoma) : S-100 & NF +ve 3. Melanoma : S-100 & HMB45 +ve 4. Small cell carcinoma : S100 & NSE Miscellaneous: Mesothelioma: Calretinin, Medullary carcinoma of thyroid: Calcitonin, Myeloma: kappa/lambda light chains, Prostate carcinoma: PSA, Hepatocellular carcinoma: AFP, Trophoblastic tumors: HCG, Gastrointestinal stromal tumors: CD117 (c-Kit), Mantle cell lymphoma: Cyclin D1

7 CD 19 1.Lymphoma 2.Neuroblastoma 3.Rhabdomyosarcoma 4.Melanoma

A 49-year-old man complains of pain in his left thigh for 3 months. On physical examination his thigh is increased in size, compared to the right. A plain film radiograph reveals the presence of a 15 cm solid mass that does not appear to arise from bone, but it does have infiltrative margins. A biopsy of this mass is taken, and on microscopic examination the mass is composed of highly pleomorphic spindle cells. Which of the following immunohistochemical markers is most likely to be demonstrated in the cells of this mass? A Cytokeratin B Factor VIII C Alpha fetoprotein D Lambda light chain E Vimentin

9 S100 If also positive for 1.NF - ? 2.Chromogranin - ? 3.HMB45 - ?

Molecular diagnosis Cytogenetic analysis PCR assays ( polymerase chain reaction) FISH ( fluorescent in-situ hybridisation) Tissue arrays Useful in diagnosis, prognosis Minimal residual disease, To detect hereditary predisposition to cancer

Flow Cytometry Rapid quantitative analysis of cell features like membrane antigens, DNA content Identification of cell surface antigens in leukemias/lymphomas Ploidy analysis in solid tumours

TUMOR MARKERASSOCIATED CANCER AFPHepatocellular carcinoma, yolk sac tumor (endodermal sinus tumor) of ovary or testis Bence Jones protein Multiple myeloma, Waldenström's macroglobulinemia (represent light chains in urine) CA 15-3Breast carcinoma CA 19-9Pancreatic, colorectal carcinomas CA 125Surface-derived ovarian cancer (e.g., serous cystadenocarcinoma; helpful in distinguishing benign from malignant tumors) CEAColorectal and pancreatic carcinomas (monitor for recurrences) LDHMalignant lymphoma (prognostic factor for response to standard therapy) PSAProstate carcinoma (also increased in prostate hyperplasia)

CEA (Carcinoembryonic Antigen) Glycoprotein, produced by embryonic tissue of gut/pancreas/liver Increased in Cancer of Colon, Pancreas, Breast Also increased in benign disorders – alcoholic cirrhosis, hepatitis, ulcerative colitis Useful in postoperative detection of residual disease / recurrence of colon cancer, monitoring treatment of breast cancer

AFP (Alpha Feto-Protein) Glycoprotein, produced by yolk sac/fetal liver/GIT Increased in Cancer of liver / germ cell tumors of testes Also increased in benign disorders – alcoholic cirrhosis, hepatitis, toxic liver injury, pregnancy Useful in post-therapy measurement – index of response to therapy / recurrence

Electron microscopy in cancer Carcinomas: Tonofilaments, desmosomes Neuroendocrine tumors: Secretory granules Malignant melanoma: Melanosomes Langerhan cell histiocytosis: Birbeck granules Insulinoma: Crystal containing granules

Required reading: Robbins Basic Pathology 9E, p Recommended reading: Robbins and Cotran Pathologic Basis of Disease 8E, p